Yuxuan Guo1, Nathan J VanDusen1, Lina Zhang1, Weiliang Gu1, Isha Sethi1, Silvia Guatimosim1, Qing Ma1, Blake D Jardin1, Yulan Ai1, Donghui Zhang1, Biyi Chen1, Ang Guo1, Guo-Cheng Yuan1, Long-Sheng Song1, William T Pu2. 1. From the Cardiology, Boston Children's Hospital, MA (Y.G., N.J.V., Q.M., B.D.J., Y.A., D.Z., W.T.P.); Institute of Basic Medicine (L.Z.) and Pharmacology, School of Pharmacy (W.G.), Shanghai University of Traditional Chinese Medicine, China; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (I.S., G.-C.Y.); Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil (S.G.); Cardiovascular Medicine, Department of Internal Medicine, François M. Abboud Cardiovascular Research Center, University of Iowa Carver College of Medicine, Iowa City (B.C., A.G., L.-S.S.); Veterans Affairs Medical Center, Iowa City (L.-S.S.); and Harvard Stem Cell Institute, Cambridge, MA (W.T.P.). 2. From the Cardiology, Boston Children's Hospital, MA (Y.G., N.J.V., Q.M., B.D.J., Y.A., D.Z., W.T.P.); Institute of Basic Medicine (L.Z.) and Pharmacology, School of Pharmacy (W.G.), Shanghai University of Traditional Chinese Medicine, China; Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA (I.S., G.-C.Y.); Physiology and Biophysics, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil (S.G.); Cardiovascular Medicine, Department of Internal Medicine, François M. Abboud Cardiovascular Research Center, University of Iowa Carver College of Medicine, Iowa City (B.C., A.G., L.-S.S.); Veterans Affairs Medical Center, Iowa City (L.-S.S.); and Harvard Stem Cell Institute, Cambridge, MA (W.T.P.). wpu@pulab.org.
Abstract
RATIONALE: Loss-of-function studies in cardiac myocytes (CMs) are currently limited by the need for appropriate conditional knockout alleles. The factors that regulate CM maturation are poorly understood. Previous studies on CM maturation have been confounded by heart dysfunction caused by whole organ gene inactivation. OBJECTIVE: To develop a new technical platform to rapidly characterize cell-autonomous gene function in postnatal murine CMs and apply it to identify genes that regulate transverse tubules (T-tubules), a hallmark of mature CMs. METHODS AND RESULTS: We developed CRISPR/Cas9/AAV9-based somatic mutagenesis, a platform in which AAV9 delivers tandem guide RNAs targeting a gene of interest and cardiac troponin-T promoter-driven Cre to RosaCas9GFP/Cas9GFP neonatal mice. When directed against junctophilin-2 (Jph2), a gene previously implicated in T-tubule maturation, we achieved efficient, rapid, and CM-specific JPH2 depletion. High-dose AAV9 ablated JPH2 in 64% CMs and caused lethal heart failure, whereas low-dose AAV9 ablated JPH2 in 22% CMs and preserved normal heart function. In the context of preserved heart function, CMs lacking JPH2 developed T-tubules that were nearly morphologically normal, indicating that JPH2 does not have a major, cell-autonomous role in T-tubule maturation. However, in hearts with severe dysfunction, both adeno-associated virus-transduced and nontransduced CMs exhibited T-tubule disruption, which was more severe in the transduced subset. These data indicate that cardiac dysfunction disrupts T-tubule structure and that JPH2 protects T-tubules in this context. We then used CRISPR/Cas9/AAV9-based somatic mutagenesis to screen 8 additional genes for required, cell-autonomous roles in T-tubule formation. We identified RYR2 (Ryanodine Receptor-2) as a novel, cell-autonomously required T-tubule maturation factor. CONCLUSIONS: CRISPR/Cas9/AAV9-based somatic mutagenesis is a powerful tool to study cell-autonomous gene functions. Genetic mosaics are invaluable to accurately define cell-autonomous gene function. JPH2 has a minor role in normal T-tubule maturation but is required to stabilize T-tubules in the failing heart. RYR2 is a novel T-tubule maturation factor.
RATIONALE: Loss-of-function studies in cardiac myocytes (CMs) are currently limited by the need for appropriate conditional knockout alleles. The factors that regulate CM maturation are poorly understood. Previous studies on CM maturation have been confounded by heart dysfunction caused by whole organ gene inactivation. OBJECTIVE: To develop a new technical platform to rapidly characterize cell-autonomous gene function in postnatal murine CMs and apply it to identify genes that regulate transverse tubules (T-tubules), a hallmark of mature CMs. METHODS AND RESULTS: We developed CRISPR/Cas9/AAV9-based somatic mutagenesis, a platform in which AAV9 delivers tandem guide RNAs targeting a gene of interest and cardiac troponin-T promoter-driven Cre to RosaCas9GFP/Cas9GFP neonatal mice. When directed against junctophilin-2 (Jph2), a gene previously implicated in T-tubule maturation, we achieved efficient, rapid, and CM-specific JPH2 depletion. High-dose AAV9 ablated JPH2 in 64% CMs and caused lethal heart failure, whereas low-dose AAV9 ablated JPH2 in 22% CMs and preserved normal heart function. In the context of preserved heart function, CMs lacking JPH2 developed T-tubules that were nearly morphologically normal, indicating that JPH2 does not have a major, cell-autonomous role in T-tubule maturation. However, in hearts with severe dysfunction, both adeno-associated virus-transduced and nontransduced CMs exhibited T-tubule disruption, which was more severe in the transduced subset. These data indicate that cardiac dysfunction disrupts T-tubule structure and that JPH2 protects T-tubules in this context. We then used CRISPR/Cas9/AAV9-based somatic mutagenesis to screen 8 additional genes for required, cell-autonomous roles in T-tubule formation. We identified RYR2 (Ryanodine Receptor-2) as a novel, cell-autonomously required T-tubule maturation factor. CONCLUSIONS: CRISPR/Cas9/AAV9-based somatic mutagenesis is a powerful tool to study cell-autonomous gene functions. Genetic mosaics are invaluable to accurately define cell-autonomous gene function. JPH2 has a minor role in normal T-tubule maturation but is required to stabilize T-tubules in the failing heart. RYR2 is a novel T-tubule maturation factor.
Authors: Christina A Pacak; Cathryn S Mah; Bijoy D Thattaliyath; Thomas J Conlon; Melissa A Lewis; Denise E Cloutier; Irene Zolotukhin; Alice F Tarantal; Barry J Byrne Journal: Circ Res Date: 2006-07-27 Impact factor: 17.367
Authors: Biyi Chen; Ang Guo; Caimei Zhang; Rong Chen; Yanqi Zhu; Jiang Hong; William Kutschke; Kathy Zimmerman; Robert M Weiss; Leonid Zingman; Mark E Anderson; Xander H T Wehrens; Long-Sheng Song Journal: Cardiovasc Res Date: 2013-07-16 Impact factor: 10.787
Authors: Zhiqiang Lin; Alexander von Gise; Pingzhu Zhou; Fei Gu; Qing Ma; Jianming Jiang; Allan L Yau; Jessica N Buck; Katryna A Gouin; Pim R R van Gorp; Bin Zhou; Jinghai Chen; Jonathan G Seidman; Da-Zhi Wang; William T Pu Journal: Circ Res Date: 2014-05-15 Impact factor: 17.367
Authors: Terence W Prendiville; Haidong Guo; Zhiqiang Lin; Pingzhu Zhou; Sean M Stevens; Aibin He; Nathan VanDusen; Jinghai Chen; Li Zhong; Da-Zhi Wang; Guangping Gao; William T Pu Journal: PLoS One Date: 2015-05-29 Impact factor: 3.240
Authors: Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell Journal: Circulation Date: 2018-11-20 Impact factor: 29.690
Authors: Xiaolu Pan; Leonne Philippen; Satadru K Lahiri; Ciaran Lee; So Hyun Park; Tarah A Word; Na Li; Kelsey E Jarrett; Rajat Gupta; Julia O Reynolds; Jean Lin; Gang Bao; William R Lagor; Xander H T Wehrens Journal: Circ Res Date: 2018-09-28 Impact factor: 17.367